Evidence map›Paper›PMID 25251219›Full record

ArticlePloS one2014

Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.

Rao Mukkavilli, Sushma R Gundala, Chunhua Yang, Shashikiran Donthamsetty, Guilherme Cantuaria, Gajanan R Jadhav, Subrahmanyam Vangala, Michelle D Reid, Ritu Aneja

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Noscapine recirculates enterohepatically and induces self-clearance.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2015
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rao MukkavilliAdvinus Therapeutics Limited, Bangalore, Karnataka, India.
Sushma R GundalaDepartment of Biology, Georgia State University, Atlanta, Georgia, United States of America.
Chunhua YangDepartment of Biology, Georgia State University, Atlanta, Georgia, United States of America.
Shashikiran DonthamsettyDepartment of Biology, Georgia State University, Atlanta, Georgia, United States of America.
Guilherme CantuariaNorthside Hospital Cancer Institute, Atlanta, Georgia, United States of America.
Gajanan R JadhavAdvinus Therapeutics Limited, Bangalore, Karnataka, India.
Subrahmanyam VangalaAdvinus Therapeutics Limited, Bangalore, Karnataka, India.
Michelle D ReidDepartment of Pathology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Ritu AnejaDepartment of Biology, Georgia State University, Atlanta, Georgia, United States of America.
Georgia State University · USEmory University · USNorthside Hospital · US

Funding

Evaluation of HSET as a Novel Theranostic Target for Breast Cancer TherapyR01CA169127 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2012 to 2016
$1.7M
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agentR00CA131489 · NCI · GEORGIA STATE UNIVERSITY · PI ANEJA, RITU · 2010 to 2012
$732k
NCI NIH HHS R00 CA131489NCI NIH HHS R00CA131489NCI NIH HHS R01 CA169127
6 · The paper itself

Abstract

Natural and complementary therapies in conjunction with mainstream cancer care are steadily gaining popularity. Ginger extract (GE) confers significant health-promoting benefits owing to complex additive and/or synergistic interactions between its bioactive constituents. Recently, we showed that preservation of natural "milieu" confers superior anticancer activity on GE over its constituent phytochemicals, 6-gingerol (6G), 8-gingerol (8 G), 10-gingerol (10 G) and 6-shogaol (6S), through enterohepatic recirculation. Here we further evaluate and compare the effects of GE and its major bioactive constituents on cytochrome P450 (CYP) enzyme activity in human liver microsomes by monitoring metabolites of CYP-specific substrates using LC/MS/MS detection methods. Our data demonstrate that individual gingerols are potent inhibitors of CYP isozymes, whereas GE exhibits a much higher half-maximal inhibition value, indicating no possible herb-drug interactions. However, GE's inhibition of CYP1A2 and CYP2C8 reflects additive interactions among the constituents. In addition, studies performed to evaluate transporter-mediated intestinal efflux using Caco-2 cells revealed that GE and its phenolics are not substrates of P-glycoprotein (Pgp). Intriguingly, however, 10 G and 6S were not detected in the receiver compartment, indicating possible biotransformation across the Caco-2 monolayer. These data strengthen the notion that an interplay of complex interactions among ginger phytochemicals when fed as whole extract dictates its bioactivity highlighting the importance of consuming whole foods over single agents. Our study substantiates the need for an in-depth analysis of hepatic biotransformation events and distribution profiles of GE and its active phenolics for the design of safe regimens.

Indexed as

Caco-2 CellsCatecholsCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemFatty AlcoholsGene Expression RegulationHumansIntestinal MucosaMicrosomes, LiverPlant ExtractsZingiber officinale8-gingerolCatecholsCytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemFatty AlcoholsgingerolPlant Extractsshogaol

Identifiers

PMID25251219
PMCPMC4177392
OpenAlexW2017262942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.